Lucian Pop
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lucian Pop has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Nicolae Bacalbasa
Department of Surgery, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania
19 shared publications - Irina Balescu
Department of Surgery, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania
16 shared publications Andrei Voichitoiu
Department of Obstetrics and Gynecology, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania
15 shared publicationsClaudia Stoica
Department of Anatomy, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania
15 shared publicationsCristina Martac
Department of Anesthesiology, Fundeni Clinical Institute, Bucharest, Romania
15 shared publications- Valentin Varlas
Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania
15 shared publications
Latest Publications
- Open Access
Prenatal Detection of Silver–Russell Syndrome: A First Trimester Suspicion and Diagnostic Approach
Background and Objectives: Silver–Russell Syndrome (SRS) is a rare genetic disorder characterized by prenatal and postnatal growth restriction, distinctive facial features, and body asymmetry. Early suspicion during the first trimester remains challenging but crucial for optimizing clinical outcomes. This study aims to highlight a diagnostic approach to the early suspicion of SRS. Materials and Methods: A 28-year-old primigravida presented for routine first-trimester prenatal care. An ultrasound revealed asymmetric growth restriction with normal anatomical findings. The first-trimester biochemical markers, including PAPP-A and β-hCG, were within the normal range. A further evaluation, including amniocentesis and genetic testing, was performed. Results: Genetic testing identified hypomethylation at the 11p15 imprinting control region, confirming the diagnosis of SRS. Parental testing excluded the maternal uniparental disomy of chromosome 7, suggesting an epigenetic mechanism. The findings were consistent with a clinical diagnosis of SRS, and appropriate counseling and multidisciplinary management were initiated. Conclusions: This case underscores the importance of the early recognition of atypical growth patterns, the integration of advanced genetic testing, and multidisciplinary counseling to guide parental decision-making and improve outcomes.
Open AccessPrenatal Detection of Silver–Russell Syndrome: A First Trimester Suspicion and Diagnostic Approach
Background and Objectives: Silver–Russell Syndrome (SRS) is a rare genetic disorder characterized by prenatal and postnatal growth restriction, distinctive facial features, and body asymmetry. Early suspicion during the first trimester remains challenging but crucial for optimizing clinical outcomes. This study aims to highlight a diagnostic approach to the early suspicion of SRS. Materials and Methods: A 28-year-old primigravida presented for routine first-trimester prenatal care. An ultrasound revealed asymmetric growth restriction with normal anatomical findings. The first-trimester biochemical markers, including PAPP-A and β-hCG, were within the normal range. A further evaluation, including amniocentesis and genetic testing, was performed. Results: Genetic testing identified hypomethylation at the 11p15 imprinting control region, confirming the diagnosis of SRS. Parental testing excluded the maternal uniparental disomy of chromosome 7, suggesting an epigenetic mechanism. The findings were consistent with a clinical diagnosis of SRS, and appropriate counseling and multidisciplinary management were initiated. Conclusions: This case underscores the importance of the early recognition of atypical growth patterns, the integration of advanced genetic testing, and multidisciplinary counseling to guide parental decision-making and improve outcomes.
- Open Access
- 5 December 2024
- Published by MDPI AG in Preprints.org
Prenatal Detection of Silver-Russell Syndrome: A First Trimester Suspicion and Diagnostic Approach
Background and Objectives: Silver-Russell Syndrome (SRS) is a rare genetic disorder characterized by prenatal and postnatal growth restriction, body asymmetry, and distinctive facial features. Antenatal diagnosis remains challenging due to subtle first-trimester manifestations. This report highlights the integration of clinical, imaging, and genetic tools for early detection and diagnosis of SRS. Materials and Methods: A 28-year-old primigravida presented for routine first-trimester prenatal care. Ultrasound revealed asymmetric growth restriction with normal anatomical findings. First-trimester biochemical markers, including PAPP-A and β-hCG, were within the normal range. Further evaluation, including amniocentesis and genetic testing, was performed. Results: Genetic testing identified hypomethylation at the 11p15 imprinting control region, confirming the diagnosis of SRS. Parental testing excluded maternal uniparental disomy of chromosome 7, suggesting an epigenetic mechanism. The findings were consistent with a clinical diagnosis of SRS, and appropriate counseling and multidisciplinary management were initiated. Conclusions: This case demonstrates the critical role of integrating first-trimester imaging and genetic testing for early detection of SRS. Early diagnosis enables timely interventions and informed counseling, ultimately improving outcomes for affected families.
- 5 December 2024
- Published by MDPI AG in Preprints.org
Open AccessPrenatal Detection of Silver-Russell Syndrome: A First Trimester Suspicion and Diagnostic Approach
Background and Objectives: Silver-Russell Syndrome (SRS) is a rare genetic disorder characterized by prenatal and postnatal growth restriction, body asymmetry, and distinctive facial features. Antenatal diagnosis remains challenging due to subtle first-trimester manifestations. This report highlights the integration of clinical, imaging, and genetic tools for early detection and diagnosis of SRS. Materials and Methods: A 28-year-old primigravida presented for routine first-trimester prenatal care. Ultrasound revealed asymmetric growth restriction with normal anatomical findings. First-trimester biochemical markers, including PAPP-A and β-hCG, were within the normal range. Further evaluation, including amniocentesis and genetic testing, was performed. Results: Genetic testing identified hypomethylation at the 11p15 imprinting control region, confirming the diagnosis of SRS. Parental testing excluded maternal uniparental disomy of chromosome 7, suggesting an epigenetic mechanism. The findings were consistent with a clinical diagnosis of SRS, and appropriate counseling and multidisciplinary management were initiated. Conclusions: This case demonstrates the critical role of integrating first-trimester imaging and genetic testing for early detection of SRS. Early diagnosis enables timely interventions and informed counseling, ultimately improving outcomes for affected families.
- Open Access
- 12 November 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (11) , 2587
Subclinical Hypothyroidism and Gestational Hypertensive Disorders in a Cohort of Romanian Pregnant Women with Gestational Diabetes Mellitus: A Pilot Study
Objective: This study aimed to explore whether subclinical hypothyroidism (SCH) treated with levothyroxine in pregnancy complicated by gestational diabetes mellitus (GDM) is associated with an increased risk of gestational hypertensive disorders (GHDs) (gestational hypertension and preeclampsia). Methods: 96 pregnant women with GDM were enrolled in this study and grouped as per the European Thyroid Association criteria into the SCH (n = 21) and euthyroid groups (n = 75). All subjects were tested for anthropometric parameters, maternal glucose homeostasis parameters, lipid levels, thyroid function tests, and blood pressure. All GDM pregnant women received nutritional and insulin therapy where needed, and the SCH group received levothyroxine treatment. Then, the maternal and newborn outcomes were compared. Data were analyzed using Student’s t-test, Mann–Whitney U, and Chi-square tests wherever applicable. p values of 0.05). Patients with GDM and SCH treated with levothyroxine had more premature delivery than the euthyroid group (p = 0.03). Conclusions: Subclinical hypothyroidism treated with levothyroxine in women with GDM does not increase the risk of gestational hypertensive disorders, but is associated with increased risk for prematurity.
- 12 November 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (11) , 2587
Open AccessSubclinical Hypothyroidism and Gestational Hypertensive Disorders in a Cohort of Romanian Pregnant Women with Gestational Diabetes Mellitus: A Pilot Study
Objective: This study aimed to explore whether subclinical hypothyroidism (SCH) treated with levothyroxine in pregnancy complicated by gestational diabetes mellitus (GDM) is associated with an increased risk of gestational hypertensive disorders (GHDs) (gestational hypertension and preeclampsia). Methods: 96 pregnant women with GDM were enrolled in this study and grouped as per the European Thyroid Association criteria into the SCH (n = 21) and euthyroid groups (n = 75). All subjects were tested for anthropometric parameters, maternal glucose homeostasis parameters, lipid levels, thyroid function tests, and blood pressure. All GDM pregnant women received nutritional and insulin therapy where needed, and the SCH group received levothyroxine treatment. Then, the maternal and newborn outcomes were compared. Data were analyzed using Student’s t-test, Mann–Whitney U, and Chi-square tests wherever applicable. p values of 0.05). Patients with GDM and SCH treated with levothyroxine had more premature delivery than the euthyroid group (p = 0.03). Conclusions: Subclinical hypothyroidism treated with levothyroxine in women with GDM does not increase the risk of gestational hypertensive disorders, but is associated with increased risk for prematurity.
- Open Access
- 1 July 2023
- Published by Walter de Gruyter GmbH in Revista Romana de Medicina de Laborator
- Vol. 31 (3) , 163-174
The role of genetic testing in the prognosis and management of solid tumors. A literature review
Introduction: Cancer is the leading cause of death and an important impediment to increasing life expectancy in every country of the world. During the process of oncogenesis, genetic and epigenetic changes lead to abnormal expression of genes associated with cellular pathways that coordinate extremely important functions such as cell multiplication, cell differentiation, cell death, and cell cycle. Methods: There are over 200 approved biomarker-driven drugs for various types of cancer. Valuable biomarkers are analyzed to establish their importance in specific therapies. Precision medicine for oncological patients has been recognized as a valuable approach to solid tumors. Results: Various genes and their mutations either have a direct pathogenic effect or can give hints to a certain prognosis regarding the oncological pathology. A comprehensive genetic test for a broad molecular profile and complete characterization of tumor genetic heterogenicity should contain genes that are aligned with professional practice, guidelines and clinical trials, full coding region coverage for each gene and targeting of unique emerging and actionable markers. It is useful to use such a comprehensive test when a broad genomic profile identifies treatment options including immunotherapies and targeted drugs for patient enrollment or when relapse or disease progression has occurred after prior therapies. Conclusions: For patients
- 1 July 2023
- Published by Walter de Gruyter GmbH in Revista Romana de Medicina de Laborator
- Vol. 31 (3) , 163-174
Open AccessThe role of genetic testing in the prognosis and management of solid tumors. A literature review
Introduction: Cancer is the leading cause of death and an important impediment to increasing life expectancy in every country of the world. During the process of oncogenesis, genetic and epigenetic changes lead to abnormal expression of genes associated with cellular pathways that coordinate extremely important functions such as cell multiplication, cell differentiation, cell death, and cell cycle. Methods: There are over 200 approved biomarker-driven drugs for various types of cancer. Valuable biomarkers are analyzed to establish their importance in specific therapies. Precision medicine for oncological patients has been recognized as a valuable approach to solid tumors. Results: Various genes and their mutations either have a direct pathogenic effect or can give hints to a certain prognosis regarding the oncological pathology. A comprehensive genetic test for a broad molecular profile and complete characterization of tumor genetic heterogenicity should contain genes that are aligned with professional practice, guidelines and clinical trials, full coding region coverage for each gene and targeting of unique emerging and actionable markers. It is useful to use such a comprehensive test when a broad genomic profile identifies treatment options including immunotherapies and targeted drugs for patient enrollment or when relapse or disease progression has occurred after prior therapies. Conclusions: For patients
- Open Access
- 12 August 2022
- Published by AMALTEA Medical Publishing House in Romanian Journal of Medical Practice
- Vol. 17 (S3) , 33-35
Does the preoperative thrombocytosis influence the postoperative outcomes in cervical cancer?
- 12 August 2022
- Published by AMALTEA Medical Publishing House in Romanian Journal of Medical Practice
- Vol. 17 (S3) , 33-35
Open AccessDoes the preoperative thrombocytosis influence the postoperative outcomes in cervical cancer?
- Open Access
- 12 August 2022
- Published by AMALTEA Medical Publishing House in Romanian Journal of Medical Practice
- Vol. 17 (S3) , 8-11
Bismuth subgallate and cervico-vaginal disorders
- 12 August 2022
- Published by AMALTEA Medical Publishing House in Romanian Journal of Medical Practice
- Vol. 17 (S3) , 8-11
Open AccessBismuth subgallate and cervico-vaginal disorders
- Open Access
- 12 August 2022
- Published by AMALTEA Medical Publishing House in Romanian Journal of Medical Practice
- Vol. 17 (S3) , 18-20
The influence of lymphocyte to monocyte ratio on the postoperative outcome of patients diagnosed with advanced stage ovarian cancer
- 12 August 2022
- Published by AMALTEA Medical Publishing House in Romanian Journal of Medical Practice
- Vol. 17 (S3) , 18-20
Open AccessThe influence of lymphocyte to monocyte ratio on the postoperative outcome of patients diagnosed with advanced stage ovarian cancer
- Open Access
- 12 August 2022
- Published by AMALTEA Medical Publishing House in Romanian Journal of Medical Practice
- Vol. 17 (S3)
The influence of platelet counts on the postoperative outcome of patients with advanced stage ovarian cancer
- 12 August 2022
- Published by AMALTEA Medical Publishing House in Romanian Journal of Medical Practice
- Vol. 17 (S3)
Open AccessThe influence of platelet counts on the postoperative outcome of patients with advanced stage ovarian cancer
- Open Access
- 12 August 2022
- Published by AMALTEA Medical Publishing House in Romanian Journal of Medical Practice
- Vol. 17 (S3) , 24-26
The impact of preoperative platelet count in vulvar cancer patients
- 12 August 2022
- Published by AMALTEA Medical Publishing House in Romanian Journal of Medical Practice
- Vol. 17 (S3) , 24-26
Open AccessThe impact of preoperative platelet count in vulvar cancer patients
- Open Access
- 12 August 2022
- Published by AMALTEA Medical Publishing House in Romanian Journal of Medical Practice
- Vol. 17 (S3) , 30-32
Is liver resection justified for ovarian sarcoma liver metastases?
- 12 August 2022
- Published by AMALTEA Medical Publishing House in Romanian Journal of Medical Practice
- Vol. 17 (S3) , 30-32
Open AccessIs liver resection justified for ovarian sarcoma liver metastases?